CoChat
Sign Up
Cited by 8

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Biocompatibility and toxicity challenges of nanomaterials

Yaşayan, Gökçen, Alarcin, Emine, Avci-Adali, Meltem, Ipek, Tuba Canak, Nejati, Omid, Özcan-Bülbül, Ece, Karslı, Seher, Bal-Öztürk, Ayça, Mostafavi, Ebrahim·2024·Functionalized Nanomaterials for Cancer Research
DOI 10.1016/b978-0-443-15518-5.00019-7
Open this paper in CoChat — free account

Overview

Integrity signals

Registry

Crossref · 10.1016/b978-0-443-15518-5.00019-7

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 4 references

Research works printed but not linked: 236

  1. Rai, 2021, Recent advances and implication of bioengineered nanomaterials in cancer theranostics, Medicina., 57, 91, 10.3390/medicina57020091 · DOI
  2. Cheng, 2021, Nanomaterials for cancer therapy: current progress and perspectives, J Hematol Oncol, 14, 1, 10.1186/s13045-021-01096-0 · DOI
  3. Andraos, 2021, Intracellular and extracellular targets as mechanisms of cancer therapy by nanomaterials in relation to their physicochemical properties, Wiley Interdiscip Rev: Nanomed Nanobiotechnol, 13, e1680
  4. Abbasi Kajani, 2021, Recent advances in nanomaterials development for nanomedicine and cancer, ACS Appl Bio Mater, 4, 5908, 10.1021/acsabm.1c00591 · DOI
  5. Singh, 2022, Cancer targeting and diagnosis: recent trends with carbon nanotubes, Nanomaterials., 12, 2283, 10.3390/nano12132283 · DOI
  6. Li, 2015, Effects of physicochemical properties of nanomaterials on their toxicity, J Biomed Mater Res Part A, 103, 2499, 10.1002/jbm.a.35384 · DOI
  7. Kus-Liśkiewicz, 2021, Biocompatibility and cytotoxicity of gold nanoparticles: recent advances in methodologies and regulations, Int J Mol Sci, 22, 10952, 10.3390/ijms222010952 · DOI
  8. Li, 2012, Biocompatibility and toxicity of nanoparticles and nanotubes, J Nanomater, 2012, 1, 10.1155/2012/591278 · DOI
  9. Egbuna, 2021, Toxicity of nanoparticles in biomedical application: nanotoxicology, J Toxicol, 2021, 1, 10.1155/2021/9954443 · DOI
  10. Nikzamir, 2021, An overview on nanoparticles used in biomedicine and their cytotoxicity, J Drug Deliv Sci Technol, 61, 102316, 10.1016/j.jddst.2020.102316 · DOI
  11. Ealia S.A.M., Saravanakumar M., editors. A review on the classification, characterisation, synthesis of nanoparticles and their application. In: IOP conference series: materials science and engineering. IOP Publishing; 2017.
  12. AL-Hadedee, 2020, Biocompatibility of nanoparticles and some of it’s applications, Biochem Cell Arch, 20, 131
  13. Adabi, 2017, Biocompatibility and nanostructured materials: applications in nanomedicine, Artif Cells, Nanomed, Biotechnol, 45, 833, 10.1080/21691401.2016.1178134 · DOI
  14. Hua, 2013, Selective collection and detection of MCF-7 breast cancer cells using aptamer-functionalized magnetic beads and quantum dots based nano-bio-probes, Anal Chim Acta, 788, 135, 10.1016/j.aca.2013.06.001 · DOI
  15. Kyriakides, 2021, Biocompatibility of nanomaterials and their immunological properties, Biomed Mater, 16, 042005, 10.1088/1748-605X/abe5fa · DOI
  16. Meng, 2021, Engineering of anticancer drugs entrapped polymeric nanoparticles for the treatment of colorectal cancer therapy, Process Biochem, 111, 36, 10.1016/j.procbio.2021.09.013 · DOI
  17. Yurtdaş-Kırımlıoğlu, 2022, Nanoarchitectonics of PLGA based polymeric nanoparticles with oseltamivir phosphate for lung cancer therapy: in vitro-in vivo evaluation, J Drug Deliv Sci Technol, 67, 102996, 10.1016/j.jddst.2021.102996 · DOI
  18. Yıldırım, 2022, Anti-cancer activity of naringenin loaded smart polymeric nanoparticles in breast cancer, J Drug Deliv Sci Technol, 74, 103552, 10.1016/j.jddst.2022.103552 · DOI
  19. Helmi, 2021, Targeted doxorubicin delivery and release within breast cancer environment using PEGylated chitosan nanoparticles labeled with monoclonal antibodies, Int J Biol Macromol, 184, 325, 10.1016/j.ijbiomac.2021.06.014 · DOI
  20. Mirhadi, 2022, Amino acid coordination complex mediates cisplatin entrapment within PEGylated liposome: an implication in colorectal cancer therapy, Int J Pharm, 623, 121946, 10.1016/j.ijpharm.2022.121946 · DOI
  21. Luiz, 2022, Folic acid-modified curcumin-loaded liposomes for breast cancer therapy, Colloids Surf A: Physicochem Eng Asp, 645, 128935, 10.1016/j.colsurfa.2022.128935 · DOI
  22. Bhaskaran, 2022, Orally delivered solid lipid nanoparticles of irinotecan coupled with chitosan surface modification to treat colon cancer: preparation, in-vitro and in-vivo evaluations, Int J Biol Macromol, 211, 301, 10.1016/j.ijbiomac.2022.05.060 · DOI
  23. El-Menshawe, 2020, The use of new quinazolinone derivative and doxorubicin loaded solid lipid nanoparticles in reversing drug resistance in experimental cancer cell lines: a systematic study, J Drug Deliv Sci Technol, 56, 101569, 10.1016/j.jddst.2020.101569 · DOI
  24. Gadag, 2021, Development and preclinical evaluation of microneedle-assisted resveratrol loaded nanostructured lipid carriers for localized delivery to breast cancer therapy, Int J Pharm, 606, 120877, 10.1016/j.ijpharm.2021.120877 · DOI
  25. Taymouri, 2019, Biotin decorated sunitinib loaded nanostructured lipid carriers for tumor targeted chemotherapy of lung cancer, J Drug Deliv Sci Technol, 50, 237, 10.1016/j.jddst.2019.01.024 · DOI
  26. Miranda, 2021, Enhanced antitumor efficacy of lapachol-loaded nanoemulsion in breast cancer tumor model, Biomed Pharmacother, 133, 110936, 10.1016/j.biopha.2020.110936 · DOI
  27. Groo, 2020, Pyridoclax-loaded nanoemulsion for enhanced anticancer effect on ovarian cancer, Int J Pharm, 587, 119655, 10.1016/j.ijpharm.2020.119655 · DOI
  28. Ybarra, 2022, Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer, OpenNano, 7, 100053, 10.1016/j.onano.2022.100053 · DOI
  29. Bartusik-Aebisher, 2021, An analytical study of Trastuzumab-dendrimer-fluorine drug delivery system in breast cancer therapy in vitro, Biomed Pharmacother, 133, 111053, 10.1016/j.biopha.2020.111053 · DOI
  30. Tejwan, 2022, pH-responsive and targeted delivery of rutin for breast cancer therapy via folic acid-functionalized carbon dots, Diam Relat Mater, 129, 109346, 10.1016/j.diamond.2022.109346 · DOI
  31. Mansur, 2022, Carboxymethylcellulose biofunctionalized ternary quantum dots for subcellular-targeted brain cancer nanotheranostics, Int J Biol Macromol, 210, 530, 10.1016/j.ijbiomac.2022.04.207 · DOI
  32. Mahani, 2021, Doxorubicin delivery to breast cancer cells with transferrin-targeted carbon quantum dots: an in vitro and in silico study, J Drug Deliv Sci Technol, 62, 102342, 10.1016/j.jddst.2021.102342 · DOI
  33. Samimi, 2021, Preparation of carbon quantum dots-quinic acid for drug delivery of gemcitabine to breast cancer cells, J Drug Deliv Sci Technol, 61, 102287, 10.1016/j.jddst.2020.102287 · DOI
  34. Alshahrani, 2022, A judicious review on the applications of chemotherapeutic loaded nanoemulsions in cancer management, J Drug Deliv Sci Technol, 103085, 10.1016/j.jddst.2021.103085 · DOI
  35. Orza, 2014, Nanomaterials for targeted drug delivery to cancer stem cells, Drug Metab Rev, 46, 191, 10.3109/03602532.2014.900566 · DOI
  36. Zhu, 2022, Current progress in cancer treatment using nanomaterials, Front Oncol, 12
  37. Barreto, 2011, Nanomaterials: applications in cancer imaging and therapy, Adv Mater, 23, H18
  38. Gorain, 2020, Theranostic application of nanoemulsions in chemotherapy, Drug Discov Today, 25, 1174, 10.1016/j.drudis.2020.04.013 · DOI
  39. Sahu, 2017, Nanoemulsion: a novel eon in cancer chemotherapy, Mini Rev Med Chem, 17, 1778, 10.2174/1389557516666160219122755 · DOI
  40. Ambekar, 2020, Recent advances in dendrimer-based nanoplatform for cancer treatment: a review, Eur Polym J, 126, 109546, 10.1016/j.eurpolymj.2020.109546 · DOI · Paper page
  41. Saluja, 2021, Dendrimers based cancer nanotheranostics: an overview, Int J Pharm, 600, 120485, 10.1016/j.ijpharm.2021.120485 · DOI
  42. Dubey, 2021, Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer, Eur J Pharm Sci, 164, 105890, 10.1016/j.ejps.2021.105890 · DOI
  43. Yang, 2018, Aptamer-functionalized carbon nanomaterials electrochemical sensors for detecting cancer relevant biomolecules, Carbon., 129, 380, 10.1016/j.carbon.2017.12.013 · DOI
  44. Chen, 2015, Theranostic applications of carbon nanomaterials in cancer: focus on imaging and cargo delivery, J Control Release, 210, 230, 10.1016/j.jconrel.2015.04.021 · DOI
  45. Singh, 2016, Molecular functionalization of carbon nanomaterials for immuno-diagnosis of cancer, Mater Today: Proc, 3, 157
  46. Bagheri, 2021, Carbon nanomaterials as emerging nanotherapeutic platforms to tackle the rising tide of cancer–a review, Bioorgan Med Chem, 51, 116493, 10.1016/j.bmc.2021.116493 · DOI
  47. Juzenas, 2008, Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer, Adv Drug Deliv Rev, 60, 1600, 10.1016/j.addr.2008.08.004 · DOI
  48. Jana, 2022, Carbon quantum dots: a promising nanocarrier for bioimaging and drug delivery in cancer, Mater Today Commun, 104068, 10.1016/j.mtcomm.2022.104068 · DOI
  49. Dhas, 2022, Organic quantum dots: an ultrasmall nanoplatform for cancer theranostics, J Control Release, 348, 798, 10.1016/j.jconrel.2022.06.033 · DOI
  50. Li, 2021, Magnetic nanoparticles for cancer theranostics: advances and prospects, J Control Release, 335, 437, 10.1016/j.jconrel.2021.05.042 · DOI
  51. Hajba, 2016, The use of magnetic nanoparticles in cancer theranostics: toward handheld diagnostic devices, Biotechnol Adv, 34, 354, 10.1016/j.biotechadv.2016.02.001 · DOI · Paper page
  52. Singh, 2014, Magnetic nanoparticles: a novel platform for cancer theranostics, Drug Discov Today, 19, 474, 10.1016/j.drudis.2013.10.005 · DOI
  53. Ganguly, 2018, Toxicity of nanomaterials: exposure, pathways, assessment, and recent advances, ACS Biomater Sci Eng, 4, 2237, 10.1021/acsbiomaterials.8b00068 · DOI
  54. Borm, 2006, The potential risks of nanomaterials: a review carried out for ECETOC, Part Fibre Toxicol, 3, 1, 10.1186/1743-8977-3-11 · DOI
  55. Aillon, 2009, Effects of nanomaterial physicochemical properties on in vivo toxicity, Adv Drug Deliv Rev, 61, 457, 10.1016/j.addr.2009.03.010 · DOI
  56. Gatoo, 2014, Physicochemical properties of nanomaterials: implication in associated toxic manifestations, BioMed Res Int, 2014, 10.1155/2014/498420 · DOI
  57. Palombo, 2014, Pharmaceutical and toxicological properties of engineered nanomaterials for drug delivery, Annu Rev Pharmacol Toxicol, 54, 581, 10.1146/annurev-pharmtox-010611-134615 · DOI
  58. Bertrand, 2012, The journey of a drug-carrier in the body: an anatomo-physiological perspective, J Control Release, 161, 152, 10.1016/j.jconrel.2011.09.098 · DOI
  59. Aggarwal, 2009, Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy, Adv Drug Deliv Rev, 61, 428, 10.1016/j.addr.2009.03.009 · DOI · Paper page
  60. Rejman, 2004, Size-dependent internalization of particles via the pathways of clathrin-and caveolae-mediated endocytosis, Biochem J, 377, 159, 10.1042/bj20031253 · DOI
  61. Semete, 2010, In vivo evaluation of the biodistribution and safety of PLGA nanoparticles as drug delivery systems, Nanomed: Nanotechnol, Biol Med, 6, 662, 10.1016/j.nano.2010.02.002 · DOI · Paper page
  62. Nel, 2006, Toxic potential of materials at the nanolevel, Science., 311, 622, 10.1126/science.1114397 · DOI · Paper page
  63. Hoffman, 1994, Photocatalytic production of H2O2 and organic peroxides on quantum-sized semiconductor colloids, Environ Sci Technol, 28, 776, 10.1021/es00054a006 · DOI
  64. Czarny, 2018, The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression, Prog Neuro-psychopharmacol Biol Psych, 80, 309, 10.1016/j.pnpbp.2017.06.036 · DOI · Paper page
  65. El-Kenawi, 2017, Inflammation, ROS, and mutagenesis, Cancer Cell, 32, 727, 10.1016/j.ccell.2017.11.015 · DOI
  66. Brown, 2001, Size-dependent proinflammatory effects of ultrafine polystyrene particles: a role for surface area and oxidative stress in the enhanced activity of ultrafines, Toxicol Appl Pharmacol, 175, 191, 10.1006/taap.2001.9240 · DOI
  67. Donaldson, 2003, Current hypotheses on the mechanisms of toxicity of ultrafine particles, Ann Ist Super Sanitã, 39, 405
  68. Park, 2011, The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles, Biomaterials., 32, 9810, 10.1016/j.biomaterials.2011.08.085 · DOI
  69. Kim, 2012, Size-dependent cellular toxicity of silver nanoparticles, J Biomed Mater Res Part A, 100, 1033, 10.1002/jbm.a.34053 · DOI
  70. Shi, 2013, Light induced toxicity reduction of silver nanoparticles to Tetrahymena pyriformis: effect of particle size, Aquat Toxicol, 132, 53, 10.1016/j.aquatox.2013.02.001 · DOI
  71. Gao, 2005, Mechanics of receptor-mediated endocytosis, Proc Natl Acad Sci, 102, 9469, 10.1073/pnas.0503879102 · DOI
  72. Champion, 2006, Role of target geometry in phagocytosis, Proc Natl Acad Sci, 103, 4930, 10.1073/pnas.0600997103 · DOI
  73. Hsiao, 2011, Effects of various physicochemical characteristics on the toxicities of ZnO and TiO2 nanoparticles toward human lung epithelial cells, Sci Total Environ, 409, 1219, 10.1016/j.scitotenv.2010.12.033 · DOI
  74. Chithrani, 2006, Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells, Nano Lett, 6, 662, 10.1021/nl052396o · DOI
  75. Chen, 2016, Evaluation of the intracellular uptake and cytotoxicity effect of TiO 2 nanostructures for various human oral and lung cells under dark conditions, Toxicol Res, 5, 303, 10.1039/c5tx00312a · DOI
  76. Decuzzi, 2008, The receptor-mediated endocytosis of nonspherical particles, Biophys J, 94, 3790, 10.1529/biophysj.107.120238 · DOI
  77. Doshi, 2010, Needle-shaped polymeric particles induce transient disruption of cell membranes, J R Soc Interface, 7, S403
  78. Ji, 2012, Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials, ACS Nano, 6, 5366, 10.1021/nn3012114 · DOI
  79. Sharma, 2010, Polymer particle shape independently influences binding and internalization by macrophages, J Control Release, 147, 408, 10.1016/j.jconrel.2010.07.116 · DOI
  80. Champion, 2009, Shape induced inhibition of phagocytosis of polymer particles, Pharm Res, 26, 244, 10.1007/s11095-008-9626-z · DOI
  81. Huang, 2011, The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo, ACS Nano, 5, 5390, 10.1021/nn200365a · DOI
  82. Park, 2003, Single-walled carbon nanotubes are a new class of ion channel blockers, J Biol Chem, 278, 50212, 10.1074/jbc.M310216200 · DOI
  83. Grabinski, 2007, Effect of particle dimension on biocompatibility of carbon nanomaterials, Carbon., 45, 2828, 10.1016/j.carbon.2007.08.039 · DOI
  84. Zhang, 2010, Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells, ACS Nano, 4, 3181, 10.1021/nn1007176 · DOI
  85. Moore, 2015, Nanoparticle colloidal stability in cell culture media and impact on cellular interactions, Chem Soc Rev, 44, 6287, 10.1039/C4CS00487F · DOI
  86. Deng, 2012, Plasma protein binding of positively and negatively charged polymer-coated gold nanoparticles elicits different biological responses, Nanotoxicology., 7, 314, 10.3109/17435390.2012.655342 · DOI
  87. Maffre, 2011, Characterization of protein adsorption onto FePt nanoparticles using dual-focus fluorescence correlation spectroscopy, Beilstein J Nanotechnol, 2, 374, 10.3762/bjnano.2.43 · DOI
  88. Georgieva, 2011, Surface characteristics of nanoparticles determine their intracellular fate in and processing by human blood–brain barrier endothelial cells in vitro, Mol Ther, 19, 318, 10.1038/mt.2010.236 · DOI
  89. Kohli, 2004, Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge, Int J Pharm, 275, 13, 10.1016/j.ijpharm.2003.10.038 · DOI
  90. Mohanraj, 2006, Nanoparticles-a review, Trop J Pharm Res, 5, 561
  91. Wick, 2007, The degree and kind of agglomeration affect carbon nanotube cytotoxicity, Toxicol Lett, 168, 121, 10.1016/j.toxlet.2006.08.019 · DOI
  92. Lin, 2010, Penetration of lipid membranes by gold nanoparticles: insights into cellular uptake, cytotoxicity, and their relationship, ACS Nano, 4, 5421, 10.1021/nn1010792 · DOI
  93. Chen, 2011, The role of surface charge on the uptake and biocompatibility of hydroxyapatite nanoparticles with osteoblast cells, Nanotechnology., 22, 105708, 10.1088/0957-4484/22/10/105708 · DOI
  94. Alexis, 2008, Factors affecting the clearance and biodistribution of polymeric nanoparticles, Mol Pharm, 5, 505, 10.1021/mp800051m · DOI · Paper page
  95. El Badawy, 2011, Surface charge-dependent toxicity of silver nanoparticles, Environ Sci Technol, 45, 283, 10.1021/es1034188 · DOI
  96. Roser, 1998, Surface-modified biodegradable albumin nano-and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats, Eur J Pharm Biopharm, 46, 255, 10.1016/S0939-6411(98)00038-1 · DOI
  97. Owens Iii, 2006, Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles, Int J Pharm, 307, 93, 10.1016/j.ijpharm.2005.10.010 · DOI · Paper page
  98. He, 2010, Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles, Biomaterials., 31, 3657, 10.1016/j.biomaterials.2010.01.065 · DOI · Paper page
  99. Patil, 2007, Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential, Biomaterials., 28, 4600, 10.1016/j.biomaterials.2007.07.029 · DOI
  100. Xiao, 2011, The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles, Biomaterials., 32, 3435, 10.1016/j.biomaterials.2011.01.021 · DOI · Paper page
  101. Heiden, 2007, Developmental toxicity of low generation PAMAM dendrimers in zebrafish, Toxicol Appl Pharmacol, 225, 70, 10.1016/j.taap.2007.07.009 · DOI
  102. Bhattacharjee, 2010, Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells, Part Fibre Toxicol, 7, 1, 10.1186/1743-8977-7-25 · DOI
  103. Griffitt, 2008, Effects of particle composition and species on toxicity of metallic nanomaterials in aquatic organisms, Environ Toxicol Chem: An Int J, 27, 1972, 10.1897/08-002.1 · DOI
  104. Ball, 2000, Bioavailability of iron from coal fly ash: mechanisms of mobilization and of biological effects, Inhal Toxicol, 12, 209, 10.1080/713856637 · DOI
  105. Gurr, 2005, Ultrafine titanium dioxide particles in the absence of photoactivation can induce oxidative damage to human bronchial epithelial cells, Toxicology., 213, 66, 10.1016/j.tox.2005.05.007 · DOI · Paper page
  106. Amin, 2015, Surface modification and local orientations of surface molecules in nanotherapeutics, J Control Release, 207, 131, 10.1016/j.jconrel.2015.04.017 · DOI
  107. Fam, 2020, Stealth coating of nanoparticles in drug-delivery systems, Nanomaterials., 10, 787, 10.3390/nano10040787 · DOI
  108. Bogdanov, 2015, Gold nanoparticles stabilized with MPEG-grafted poly(l-lysine): in vitro and in vivo evaluation of a potential theranostic agent, Bioconjug Chem, 26, 39, 10.1021/bc5005087 · DOI
  109. Zeng, 2022, Cell membrane coated-nanoparticles for cancer immunotherapy, Acta Pharm Sin B, 12, 3233, 10.1016/j.apsb.2022.02.023 · DOI · Paper page
  110. Li, 2010, Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting, J Control Release, 145, 178, 10.1016/j.jconrel.2010.03.016 · DOI
  111. McNamara, 2020, Chapter 10—Biomedical applications of nanoalloys, 381
  112. Han, 2018, Red blood cells as smart delivery systems, Bioconjug Chem, 29, 852, 10.1021/acs.bioconjchem.7b00758 · DOI
  113. Luk, 2015, Cell membrane-camouflaged nanoparticles for drug delivery, J Control Release, 220, 600, 10.1016/j.jconrel.2015.07.019 · DOI
  114. Gu, 2021, Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis, J Control Release, 333, 374, 10.1016/j.jconrel.2021.03.039 · DOI
  115. Yoo, 2019, Active targeting strategies using biological ligands for nanoparticle drug delivery systems, Cancers., 11, 640, 10.3390/cancers11050640 · DOI
  116. Huo, 2017, Tumor-targeted delivery of sunitinib base enhances vaccine therapy for advanced melanoma by remodeling the tumor microenvironment, J Control Release, 245, 81, 10.1016/j.jconrel.2016.11.013 · DOI
  117. Das, 2017, Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study, JBIC J Biol Inorg Chem, 22, 893, 10.1007/s00775-017-1468-x · DOI
  118. Lankoff, 2012, Effect of surface modification of silica nanoparticles on toxicity and cellular uptake by human peripheral blood lymphocytes in vitro, Nanotoxicology., 7, 235, 10.3109/17435390.2011.649796 · DOI
  119. Selim, 2012, Effect of the surface texture and crystallinity of ZnO nanoparticles on their toxicity, Mater Sci Eng: C, 32, 2356, 10.1016/j.msec.2012.07.007 · DOI
  120. Kawanishi, 2002, Free Radic Biol Med, 32, 822, 10.1016/S0891-5849(02)00779-7 · DOI
  121. Moris, 2017, The role of reactive oxygen species in the pathophysiology of cardiovascular diseases and the clinical significance of myocardial redox, Ann Transl Med, 5, 326, 10.21037/atm.2017.06.27 · DOI
  122. Dias, 2013, The role of oxidative stress in Parkinson’s disease, J Parkinsons Dis, 3, 461, 10.3233/JPD-130230 · DOI · Paper page
  123. Liu, 2021, Inorganic nanoparticles applied as functional therapeutics, Adv Funct Mater, 31, 2008171, 10.1002/adfm.202008171 · DOI
  124. Fang, 2004, Antimicrobial reactive oxygen and nitrogen species: concepts and controversies, Nat Rev Microbiol, 2, 820, 10.1038/nrmicro1004 · DOI · Paper page
  125. Wang, 2021, Titanium-based nanomaterials for cancer theranostics, Coord Chem Rev, 430, 213662, 10.1016/j.ccr.2020.213662 · DOI
  126. Feng, 2018, Hypoxia-specific therapeutic agents delivery nanotheranostics: a sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer, J Control Release, 275, 192, 10.1016/j.jconrel.2018.02.011 · DOI
  127. Eftekhari, 2018, Hepatoprotective and free radical scavenging actions of quercetin nanoparticles on aflatoxin B1-induced liver damage: in vitro/in vivo studies, Artif Cells, Nanomed, Biotechnol, 46, 411, 10.1080/21691401.2017.1315427 · DOI
  128. Abdal Dayem, 2017, The role of reactive oxygen species (ROS) in the biological activities of metallic nanoparticles, Int J Mol Sci, 18, 120, 10.3390/ijms18010120 · DOI
  129. Akhtar, 2017, Mechanism of ROS scavenging and antioxidant signalling by redox metallic and fullerene nanomaterials: potential implications in ROS associated degenerative disorders, Biochim Biophys Acta (BBA)—Gen Subj, 1861, 802, 10.1016/j.bbagen.2017.01.018 · DOI
  130. Akhtar, 2015, Antioxidative and cytoprotective response elicited by molybdenum nanoparticles in human cells, J Colloid Interface Sci, 457, 370, 10.1016/j.jcis.2015.07.034 · DOI
  131. Akter, 2018, A systematic review on silver nanoparticles-induced cytotoxicity: physicochemical properties and perspectives, J Adv Res, 9, 1, 10.1016/j.jare.2017.10.008 · DOI
  132. Shukla, 2021, Genotoxic potential of nanoparticles: structural and functional modifications in DNA, Front Genet, 12, 728250, 10.3389/fgene.2021.728250 · DOI
  133. Weiss, 2021, Combined in vitro and in vivo approaches to propose a putative adverse outcome pathway for acute lung inflammation induced by nanoparticles: a study on carbon dots, Nanomaterials., 11, 180, 10.3390/nano11010180 · DOI
  134. Cao, 2021, Reactive oxygen species-sensitive polymeric nanocarriers for synergistic cancer therapy, Acta Biomater, 130, 17, 10.1016/j.actbio.2021.05.023 · DOI
  135. Kawanishi, 2002, The role of metals in site-specific DNA damage with reference to carcinogenesis, Free Radic Biol Med, 32, 822, 10.1016/S0891-5849(02)00779-7 · DOI
  136. Kang, 2008, Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes, Environ Mol Mutagen, 49, 399, 10.1002/em.20399 · DOI
  137. Yu, 2020, Reactive oxygen species-related nanoparticle toxicity in the biomedical field, Nanoscale Res Lett, 15, 115, 10.1186/s11671-020-03344-7 · DOI
  138. Murphy, 2009, How mitochondria produce reactive oxygen species, Biochem J, 417, 1, 10.1042/BJ20081386 · DOI · Paper page
  139. Xu, 2016, Reactive oxygen species (ROS) responsive polymers for biomedical applications, Macromol Biosci, 16, 635, 10.1002/mabi.201500440 · DOI
  140. Manke, 2013, Mechanisms of nanoparticle-induced oxidative stress and toxicity, BioMed Res Int, 2013, 10.1155/2013/942916 · DOI
  141. Rajoria, 2019, Glycine-poly-L-lactic acid copolymeric nanoparticles for the efficient delivery of bortezomib, Pharm Res, 36, 1, 10.1007/s11095-019-2686-4 · DOI
  142. Fu, 2014, Mechanisms of nanotoxicity: generation of reactive oxygen species, J Food Drug Anal, 22, 64, 10.1016/j.jfda.2014.01.005 · DOI
  143. Barillet, 2010, Toxicological consequences of TiO2, SiC nanoparticles and multi-walled carbon nanotubes exposure in several mammalian cell types: an in vitro study, J Nanopart Res, 12, 61, 10.1007/s11051-009-9694-y · DOI
  144. Liao, 2019, The size-dependent genotoxic potentials of titanium dioxide nanoparticles to endothelial cells, Environ Toxicol, 34, 1199, 10.1002/tox.22821 · DOI
  145. Sohaebuddin, 2010, Nanomaterial cytotoxicity is composition, size, and cell type dependent, Particle Fibre Toxicol., 7, 22, 10.1186/1743-8977-7-22 · DOI
  146. Hussain, 2014, Intracellular signal modulation by nanomaterials, Adv Exp Med Biol, 811, 111, 10.1007/978-94-017-8739-0_7 · DOI
  147. Fubini, 2003, Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis, Free Radic Biol Med, 34, 1507, 10.1016/S0891-5849(03)00149-7 · DOI · Paper page
  148. Lee, 2018, Editor’s highlight: a genome-wide screening of target genes against silver nanoparticles in fission yeast, Toxicol Sci, 161, 171, 10.1093/toxsci/kfx208 · DOI
  149. Gaetke, 2003, Copper toxicity, oxidative stress, and antioxidant nutrients, Toxicology., 189, 147, 10.1016/S0300-483X(03)00159-8 · DOI
  150. Wilhelmi, 2013, Zinc oxide nanoparticles induce necrosis and apoptosis in macrophages in a p47phox- and Nrf2-independent manner, PLOS ONE, 8, e65704, 10.1371/journal.pone.0065704 · DOI
  151. Culcasi, 2012, EPR spin trapping evaluation of ROS production in human fibroblasts exposed to cerium oxide nanoparticles: evidence for NADPH oxidase and mitochondrial stimulation, Chem-Biol Interact, 199, 161, 10.1016/j.cbi.2012.08.007 · DOI
  152. Raghunathan, 2013, Influence of particle size and reactive oxygen species on cobalt chrome nanoparticle-mediated genotoxicity, Biomaterials., 34, 3559, 10.1016/j.biomaterials.2013.01.085 · DOI
  153. Sun, 2017, NOX4- and Nrf2-mediated oxidative stress induced by silver nanoparticles in vascular endothelial cells, J Appl Toxicol, 37, 1428, 10.1002/jat.3511 · DOI
  154. Akhtar, 2010, Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells, Toxicology., 276, 95, 10.1016/j.tox.2010.07.010 · DOI
  155. Akhtar, 2012, Protective effect of sulphoraphane against oxidative stress mediated toxicity induced by CuO nanoparticles in mouse embryonic fibroblasts BALB 3T3, J Toxicol Sci, 37, 139, 10.2131/jts.37.139 · DOI
  156. Zhang, 2009, Autophagy-mediated chemosensitization in cancer cells by fullerene C60 nanocrystal, Autophagy., 5, 1107, 10.4161/auto.5.8.9842 · DOI
  157. Bosi, 2003, Fullerene derivatives: an attractive tool for biological applications, Eur J Med Chem, 38, 913, 10.1016/j.ejmech.2003.09.005 · DOI
  158. Kohl, 2020, Genotoxicity of nanomaterials: advanced in vitro models and high throughput methods for human hazard assessment—a review, Nanomaterials., 10, 1911, 10.3390/nano10101911 · DOI
  159. Siivola, 2022, A systematic quality evaluation and review of nanomaterial genotoxicity studies: a regulatory perspective, Part fibre Toxicol, 19, 1
  160. Magdolenova, 2015, Coating-dependent induction of cytotoxicity and genotoxicity of iron oxide nanoparticles, Nanotoxicology., 9, 44, 10.3109/17435390.2013.847505 · DOI
  161. Vallabani, 2022, Primary and secondary genotoxicity of nanoparticles: establishing a co-culture protocol for assessing micronucleus using flow cytometry, Front Toxicol, 28
  162. Elespuru, 2022, Common considerations for genotoxicity assessment of nanomaterials, Front Toxicol, 4, 10.3389/ftox.2022.859122 · DOI
  163. Drasler, 2017, In vitro approaches to assess the hazard of nanomaterials, NanoImpact, 8, 99, 10.1016/j.impact.2017.08.002 · DOI
  164. Pfuhler, 2013, Genotoxicity of nanomaterials: refining strategies and tests for hazard identification, Environ Mol Mutagen, 54, 229, 10.1002/em.21770 · DOI
  165. Kononenko, 2017, Comparative in vitro genotoxicity study of ZnO nanoparticles, ZnO macroparticles and ZnCl2 to MDCK kidney cells: size matters, Toxicol Vitro, 40, 256, 10.1016/j.tiv.2017.01.015 · DOI
  166. Lebedová, 2018, Size-dependent genotoxicity of silver, gold and platinum nanoparticles studied using the mini-gel comet assay and micronucleus scoring with flow cytometry, Mutagenesis., 33, 77, 10.1093/mutage/gex027 · DOI
  167. Guo, 2016, Size-and coating-dependent cytotoxicity and genotoxicity of silver nanoparticles evaluated using in vitro standard assays, Nanotoxicology., 10, 1373, 10.1080/17435390.2016.1214764 · DOI
  168. Huk, 2014, Is the toxic potential of nanosilver dependent on its size?, Part Fibre Toxicol, 11, 65, 10.1186/s12989-014-0065-1 · DOI · Paper page
  169. Gea, 2019, Shape-engineered titanium dioxide nanoparticles (TiO2-NPs): cytotoxicity and genotoxicity in bronchial epithelial cells, Food Chem Toxicol, 127, 89, 10.1016/j.fct.2019.02.043 · DOI
  170. Gábelová, 2017, Fibrous shape underlies the mutagenic and carcinogenic potential of nanosilver while surface chemistry affects the biosafety of iron oxide nanoparticles, Mutagenesis., 32, 193, 10.1093/mutage/gew045 · DOI
  171. Relier, 2017, Study of TiO2 P25 nanoparticles genotoxicity on lung, blood, and liver cells in lung overload and non-overload conditions after repeated respiratory exposure in rats, Toxicol Sci, 156, 527
  172. Poon, 2019, Elimination pathways of nanoparticles, ACS Nano, 13, 5785, 10.1021/acsnano.9b01383 · DOI
  173. Shukla, 2014, Titanium dioxide nanoparticle-induced oxidative stress triggers DNA damage and hepatic injury in mice, Nanomed (Lond), 9, 1423, 10.2217/nnm.13.100 · DOI
  174. Hubbell, 2009, Materials engineering for immunomodulation, Nature., 462, 449, 10.1038/nature08604 · DOI
  175. Dobrovolskaia, 2007, Immunological properties of engineered nanomaterials, Nat Nanotechnol, 2, 469, 10.1038/nnano.2007.223 · DOI · Paper page
  176. Kwon, 2005, Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles, J Control Release, 105, 199, 10.1016/j.jconrel.2005.02.027 · DOI
  177. Fytianos, 2017, Aerosol delivery of functionalized gold nanoparticles target and activate dendritic cells in a 3D lung cellular model, ACS Nano, 11, 375, 10.1021/acsnano.6b06061 · DOI
  178. Saleh, 2010, Influence of biomacromolecules and humic acid on the aggregation kinetics of single-walled carbon nanotubes, Environ Sci Technol, 44, 2412, 10.1021/es903059t · DOI
  179. Deng, 2011, Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation, Nat Nanotechnol, 6, 39, 10.1038/nnano.2010.250 · DOI
  180. Giovanni, 2015, Pro-inflammatory responses of RAW264.7 macrophages when treated with ultralow concentrations of silver, titanium dioxide, and zinc oxide nanoparticles, J Hazard Mater, 297, 146, 10.1016/j.jhazmat.2015.04.081 · DOI
  181. Park, 2016, Copper oxide nanoparticles aggravate airway inflammation and mucus production in asthmatic mice via MAPK signaling, Nanotoxicology., 10, 445, 10.3109/17435390.2015.1078851 · DOI
  182. Mirshafiee, 2018, Toxicological profiling of metal oxide nanoparticles in liver context reveals pyroptosis in kupffer cells and macrophages versus apoptosis in hepatocytes, ACS Nano, 12, 3836, 10.1021/acsnano.8b01086 · DOI
  183. Liang, 2017, Reactive oxygen species trigger NF-κB-mediated NLRP3 inflammasome activation induced by zinc oxide nanoparticles in A549 cells, Toxicol Ind Health, 33, 737, 10.1177/0748233717712409 · DOI
  184. Baron, 2015, The NLRP3 inflammasome is activated by nanoparticles through ATP, ADP and adenosine, Cell Death Dis, 6, 10.1038/cddis.2014.576 · DOI
  185. Forster Iii, 2022, mRNA-carrying lipid nanoparticles that induce lysosomal rupture activate NLRP3 inflammasome and reduce mRNA transfection efficiency, Biomater Sci, 10, 5566, 10.1039/D2BM00883A · DOI
  186. Sun, 2012, Pulmotoxicological effects caused by long-term titanium dioxide nanoparticles exposure in mice, J Hazard Mater, 235–236, 47, 10.1016/j.jhazmat.2012.05.072 · DOI
  187. Gui, 2011, Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles, J Hazard Mater, 195, 365, 10.1016/j.jhazmat.2011.08.055 · DOI
  188. Vasilichin, 2020, Effects of metal oxide nanoparticles on Toll-like receptor mRNAs in human monocytes, Nanomaterials., 10, 127, 10.3390/nano10010127 · DOI
  189. Cui, 2011, Signaling pathway of inflammatory responses in the mouse liver caused by TiO2 nanoparticles, J Biomed Mater Res A, 96, 221, 10.1002/jbm.a.32976 · DOI
  190. Danielsen, 2021, Nanomaterial- and shape-dependency of TLR2 and TLR4 mediated signaling following pulmonary exposure to carbonaceous nanomaterials in mice, Part Fibre Toxicol, 18, 40, 10.1186/s12989-021-00432-z · DOI
  191. Li, 2020, Research progress of nanoparticle toxicity signaling pathway, Life Sci, 263, 118542, 10.1016/j.lfs.2020.118542 · DOI
  192. Siegrist, 2017, Selective stimulation of the JAK/STAT signaling pathway by silica nanoparticles in human endothelial cells, Toxicol Vitro, 42, 308, 10.1016/j.tiv.2017.05.002 · DOI
  193. Hong, 2016, The nano-TiO2 exposure can induce hepatic inflammation involving in a JAK–STAT signalling pathway, J Nanopart Res, 18, 1, 10.1007/s11051-016-3472-4 · DOI
  194. Bundschuh, 2018, Nanoparticles in the environment: where do we come from, where do we go to?, Environ Sci Eur, 30, 6, 10.1186/s12302-018-0132-6 · DOI
  195. Rocha, 2015, Ecotoxicological impact of engineered nanomaterials in bivalve molluscs: an overview, Mar Env Res, 111, 74, 10.1016/j.marenvres.2015.06.013 · DOI
  196. Zielinska, 2020, Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology, Molecules., 25, 10.3390/molecules25163731 · DOI · Paper page
  197. Mulenos, 2020, Copper, silver, and titania nanoparticles do not release ions under anoxic conditions and release only minute ion levels under oxic conditions in water: evidence for the low toxicity of nanoparticles, Environ Chem Lett, 18, 1319, 10.1007/s10311-020-00985-z · DOI
  198. Parks, 2014, Effects of single-walled carbon nanotubes on the bioavailability of PCBs in field-contaminated sediments, Nanotoxicology., 8, 111, 10.3109/17435390.2013.858794 · DOI
  199. Boyes, 2017, A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials, Crit Rev Toxicol, 47, 767, 10.1080/10408444.2017.1328400 · DOI
  200. Federici, 2007, Toxicity of titanium dioxide nanoparticles to rainbow trout (Oncorhynchus mykiss): gill injury, oxidative stress, and other physiological effects, Aquat Toxicol, 84, 415, 10.1016/j.aquatox.2007.07.009 · DOI

200 of 236 shown

Cited by

Sorted by citations

Metadata

Authors
Yaşayan, G., Alarcin, E., Avci-Adali, M., Ipek, T. C., Nejati, O., Özcan-Bülbül, E., Karslı, S., Bal-Öztürk, A., & Mostafavi, E.
Venue
Functionalized Nanomaterials for Cancer Research
Publisher
Elsevier
Published
2024
Pages
603-631
DOI
10.1016/b978-0-443-15518-5.00019-7
Cited by
8
References
4
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review